Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
The drug is currently being evaluated in Phase III clinical development
Progress on a GLP-1 also depends on dose timing, food tolerance, protein, fiber, water, side effects, and consistency
GLP-1s drive aggressive caloric restriction, which accelerates lean-muscle loss and can impair liver fat clearance
Many individuals experience transient gastrointestinal symptoms during the initial weeks of treatment or following dose escalation, with symptoms often improving as the body adapts to the medication
US$ 29.94
US$ 20.60
US$ 23.12
US$ 24.41
